Related Experiment Video
Updated: Jul 24, 2025

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Spinal CBX2 contributes to neuropathic pain by activating ERK signaling pathway in male mice
Meiling Han1, Fan Zhang1, Ying Wang1
1Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China; Department of Anesthesiology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
Abstract:
The deregulated spinal cord proteins induced by nerve injury are the key to neuropathic pain. Integrated transcriptome and translatome analyses can screen out deregulated proteins controlled by only post-transcriptional regulation. By comparing RNA sequencing (RNA-seq) and ribosome profiling sequencing (Ribo-seq) data, we identified an upregulated protein, chromobox 2 (CBX2), with its mRNA level unchanged in the spinal cord after peripheral nerve injury. CBX2 was mainly distributed in the spinal cord neurons. Blocking the SNL-induced increase of spinal CBX2 attenuated the neuronal and astrocytes hyperactivities and pain hypersensitivities in both the development and maintenance phases. Conversely, mimicking the upregulation of CBX2 in the spinal cord facilitated the activities of neurons and astrocytes and produced evoked nociceptive hypersensitivity and spontaneous pain. Our results also revealed that activating the ERK pathway, upregulating CXCL13 in neurons, and CXCL13 further inducing astrocyte activation were possible downstream signaling mechanisms of CBX2 in pain processing. In conclusion, upregulation of CBX2 after nerve injury leads to nociceptive hyperalgesia by promoting neuronal and astrocyte hyperactivities through the ERK pathway. Inhibiting CBX2 upregulation may be therapeutically beneficial.
Insights
Nerve injury causes neuropathic pain by upregulating chromobox 2 (CBX2) protein post-transcriptionally. Inhibiting CBX2 in the spinal cord may offer therapeutic benefits for pain relief.
Area of Science:
- Neuroscience
- Molecular Biology
- Pain Research
Background:
- Neuropathic pain arises from deregulated spinal cord proteins after nerve injury.
- Post-transcriptional regulation plays a crucial role in controlling protein levels.
Purpose of the Study:
- To identify proteins regulated post-transcriptionally after nerve injury.
- To investigate the role of chromobox 2 (CBX2) in neuropathic pain.
Main Methods:
- Integrated transcriptome (RNA sequencing) and translatome (ribosome profiling sequencing) analyses.
- Investigated CBX2 distribution and function in spinal cord neurons.
- Utilized animal models of nerve injury and pain.
Main Results:
- Identified chromobox 2 (CBX2) as upregulated post-transcriptionally in the spinal cord after nerve injury.
- CBX2 upregulation promoted neuronal and astrocyte hyperactivity, leading to pain hypersensitivity.
- CBX2 activates the ERK pathway and upregulates CXCL13, contributing to astrocyte activation and pain.
Conclusions:
- Spinal cord CBX2 upregulation is a key driver of neuropathic pain.
- CBX2 influences pain processing via the ERK pathway and CXCL13 signaling.
- Targeting CBX2 may represent a novel therapeutic strategy for neuropathic pain.

